A Pilot,Raltegravir Versus NRTIs as a Backbone Switched From a Stable Boosted PI Regimen

This study has been completed.
Sponsor:
Collaborators:
Merck Sharp & Dohme Corp.
St. John's Research Institute
Information provided by (Responsible Party):
Charurut Somboonwit, University of South Florida
ClinicalTrials.gov Identifier:
NCT00749580
First received: September 5, 2008
Last updated: November 1, 2011
Last verified: November 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2011
  Primary Completion Date: July 2011 (Final data collection date for primary outcome measure)